RESUMEN
Abstract The incorrect disposal of medicines and their environmental impact has been related to the health medicalization and the improper use of medication by society. In this sense, it is very important to know the profile of drug disposal for foster health policies. The aim was to identify the profile of disposal of medicines by the population, including the cost perspective. This is an inquiry descriptive study that began in September 2019. Medicine disposal health education program was carried out over six months in two University pharmacies. A questionnaire for sociodemographic and discarded medicines data collection was applied. Logistic regression analysis for variables association of correct disposal and the chi-square and t-student analysis for comparison between disposal programs were performed for a level of 5% and test power of 80%. Medicines weighed 23.3 kg and 28.5 kg, with the cost variation from US$ 13.5 to US$ 16.1 until the final treatment. The correct disposal was strongly associated with the disposal reason (p=0.013), source of information (p=0.006), prescription (p=0.03), form of use (p=0.01), acquisition source (p=0.001), cost with medication (p=0.0001), education (p=0.028) and age (p=0.05). The correct medicine disposal was associated with important features of the community related to education health.
Asunto(s)
Residuos de Medicamentos/economía , Educación en Salud/clasificación , Ambiente , Farmacias/clasificación , Estudiantes/clasificación , Universidades/clasificación , Recolección de Datos/instrumentación , Costos y Análisis de Costo/estadística & datos numéricos , Medicalización/estadística & datos numéricosRESUMEN
Abstract The purpose of this study is to estimate the prevalence of and characterize the use of psychoactive drugs among drug users in a Brazilian municipality, relating the findings to factors associated with the consumption of these substances. Through a cross-sectional design, 1,355 drug users from the public health systems community pharmacies were interviewed. Sociodemographic and health-related data were collected, as well as any other prescribed drugs. The prevalence of psychoactive drug use within the last month was 31.0%, with antidepressants and benzodiazepines being the most prescribed (53.5% and 24.6% respectively). Most psychoactive drug users were female (81.9%), lived with a partner (52.6%), had private health insurance (69.2%) and a monthly per-capita income up to one minimum wage (54.0%). The adjusted Odds Ratio (OR) confirmed the following factors to be positively associated with the use of psychoactive drugs: female gender (OR=2.06; 95% CI 1.44; 2.95), age ≥60 years old (OR=1.77; 95% CI 1.26; 2.48), follow-up with a psychologist (OR=4.12; 95% CI 1.84; 5.25), absence of regular physical activity (OR=1.59; 95% CI 1.13; 2.23), and smokers (OR=1.94; 95% CI 1.26; 2.97). Approximately one out of three individuals used at least one psychoactive drug. Health managers should focus the planning and actions aimed at their rational use for these groups, leading to increased overall treatment success
Asunto(s)
Humanos , Masculino , Femenino , Adolescente , Adulto , Persona de Mediana Edad , Psicotrópicos/análisis , Sistema Único de Salud , Farmacias/clasificación , Farmacoepidemiología/clasificación , Consumidores de Drogas/estadística & datos numéricos , Antidepresivos/efectos adversosRESUMEN
Abstract The announcement by the WHO of the characterization of the new Coronavirus 2019 disease (COVID-19) as a pandemic, entails an adaptation by the community pharmacy in carrying out its care activity in general, with particular emphasis on "Minor Ailments Service" in particular. The measures taken by the different health administrations in which patient telephone care by primary care offices is prioritized have left more consultations on symptoms in the community pharmacist health-related problems as pharmacies are the closest health facilities to the patient. The similarity between the symptomatology caused by the new Coronavirus with that of some Enteroviruses that cause mild respiratory and gastrointestinal tables (dry cough, fever, sore throat, vomiting, diarrhoea, etc.) makes community pharmacies highly capable places for contagion detection and prevention. A model of protocolized intervention is needed to facilitate the pharmacist's work in discriminating during the indication between minor symptoms and symptoms of referral for possible cases of COVID-19 so that in conjunction with the rest of the staff we help control the disease and make better use of primary care consultations.
Asunto(s)
Farmacias/clasificación , COVID-19/prevención & control , Farmacéuticos/clasificación , Servicios Farmacéuticos/ética , Atención Primaria de Salud/clasificación , Coronavirus/patogenicidadRESUMEN
Abstract The insertion of Pharmaceutical Care in Primary Health Care (PHC) improves patients' clinical outcomes and quality of life. Pharmacotherapeutic follow-up can contribute to the management of chronic diseases such as diabetes, promoting better glycemic control and adherence to therapy. This study aimed to assess the Drug-therapy Problems (DTPs) and Pharmacist Interventions (PIs) on the pharmacotherapeutic management in patients with type 2 diabetes mellitus (T2DM) in a community pharmacy. A quantitative, retrospective, and cross-sectional study was conducted in a Pharmaceutical Care Program within the PHC in Juiz de Fora (Minas Gerais, Brazil). Inclusion criteria were patients with T2DM above 18, who attended at least three pharmaceutical consultations between July 2016 and October 2018 and presented two or more glycated hemoglobin tests. The study group (n = 17) was largely composed of women (65%), elderly (76%), sedentary (72%), and obese people (52%). The resolution was achieved in 79% of the DTPs identified (n = 115). Most of DTPs were related to administration and adherence to pharmacotherapy (46%). 60% of the 437 PIs involved the provision of information and counseling. In other words, accessible interventions lead to high resolvability. Therefore, clinical actuation of pharmacists could improve the prognosis in diabetes treatment
Asunto(s)
Humanos , Masculino , Femenino , Adolescente , Adulto , Anciano , Pacientes/clasificación , Servicios Farmacéuticos/organización & administración , Atención Primaria de Salud/organización & administración , Diabetes Mellitus Tipo 2/patología , Farmacias/clasificación , Derivación y Consulta/normas , Enfermedad Crónica/tratamiento farmacológico , Estudios Transversales/instrumentación , Farmacoepidemiología/instrumentación , Quimioterapia/clasificaciónRESUMEN
Studies that addressed the profile of pharmaceutical activities and behaviors in community pharmacies in the last decades pointed to a gap between community pharmacy practice and the precepts of the profession. Facing the need to analyze whether the new legislation has impacted this scenario, the objective of this study was to describe the general profile and academic profile of community pharmacists, and the profile of the activities they develop, as well as to know their place of work. This is a descriptive study, to which all pharmacists in charge of community pharmacies in the metropolitan area of ââBelo Horizonte-MG (n = 1624) were invited. Data collection was performed through a questionnaire validated online, from October to December 2017, via Google Docs®. Responses were obtained from 109 pharmacists, most of them female, aged 31-40 years, being general graduates, and in private institutions. Pharmacotherapeutic follow-up, an activity linked to clinical management, is performed by only 37.60% of pharmacists, evidencing that there is still a lag in relation to the provision of clinical services by community pharmacists. Thus, we emphasize the importance of implementing the precepts established by Brazilian curricular guidelines for undergraduate pharmacy courses which focus on the development of clinical skills, since the insertion of the pharmacist into the health team and the provision of clinical services to the community can add new value to the use of medications, and contribute effectively to their rational use in Brazil.
Asunto(s)
Humanos , Masculino , Femenino , Adulto , Farmacias/clasificación , Farmacéuticos/ética , Servicios Farmacéuticos/estadística & datos numéricos , Enseñanza/estadística & datos numéricos , Lugar de Trabajo/estadística & datos numéricos , Enseñanza/ética , Epidemiología DescriptivaRESUMEN
Although dispensing of medication has been addressed by theoretical models, studies that confirm the impact of this service are still needed. The objective was to evaluate the impact of a new model of medicine dispensing system on patients' medication knowledge, adherence to treatment and satisfaction. One hundred and four patients attending the dispensing service of a community pharmacy between 21 January 2013 and 20 April 2013 were included in this intervention study. The impact of the service on patients' medication knowledge, adherence to treatment and satisfaction was assessed by using validated questionnaires at two time points: at the moment of medication dispensing and 30 days thereafter by telephone contact. Statistical analysis was performed by McNemar's test, and a p<0.05 was set as statistically significant. The number of patients showing insufficient knowledge about medications decreased by 50% (p < 0.05), and the number of those showing sufficient knowledge was three times greater (p < 0.05) after medicine dispensing. A high level of satisfaction was observed. Improvement of medication adherence, however, was not observed. The proposed system model for drug dispensing improved patients' knowledge about medication and satisfaction
Asunto(s)
Humanos , Masculino , Femenino , Adolescente , Adulto , Persona de Mediana Edad , Anciano , Anciano de 80 o más Años , Farmacias/clasificación , Evaluación de Resultado en la Atención de Salud/métodos , Buenas Prácticas de Dispensación , Satisfacción del Paciente/estadística & datos numéricos , Servicios Comunitarios de Farmacia/provisión & distribuciónRESUMEN
Obesity is defined as the excess adipose tissue in the body. Drugs responsible for inhibiting the appetite are called anorectics or appetite suppressants. Sibutramine, fenproporex and amfepramone belongs to this class, and are capable of causing physical or psychological dependence. The aim of this study was to evaluate the frequency of prescriptions for appetite suppressants in community pharmacies at Cruz Alta, State of Rio Grande do Sul, Brazil. The sales of fenproporex, amfepramone and sibutramine in the months of September, October and November 2010 and April, May and June 2011 were compared. It was observed that the most commonly dispensed anorectic in the three community pharmacies analyzed was sibutramine. In the months of September, October and November 2010, consumption was higher, with sibutramine achieving 40.3% of overall sales, amfepramone 21% and, finally, fenproporex, 7.9%. The consumption of appetite suppressants was more prevalent in females, who represented 82% of total. The results suggested the existence of high consumption of anorectics, possibly related to the current concern with aesthetic standards, which emphasizes the importance of strict control over the marketing of these substances.
Obesidade define-se como excesso de tecido adiposo no organismo. Os fármacos responsáveis por inibir o apetite são denominados anorexígenos ou supressores de apetite. Sibutramina, femproporex e anfepramona, pertencentes a essa classe, são capazes de provocar dependência física ou psíquica. O objetivo deste estudo foi avaliar a prevalência da prescrição de anorexígenos em farmácias comerciais de Cruz Alta - RS. Foi comparada a venda dos fármacos femproporex, anfepramona e sibutramina, nos meses de setembro, outubro e novembro de 2010 e abril, maio e junho de 2011. Observou-se que o anorexígeno mais prescrito nas três farmácias analisadas foi a sibutramina. Nos meses de setembro, outubro e novembro de 2010, o consumo foi maior, quando a sibutramina alcançou um percentual de 40,3%, a anfepramona 21% e, por fim, o femproporex, 7,9%. O consumo de inibidores de apetite foi mais prevalente no sexo feminino, o qual representou 82% do total. Os resultados sugeriram a existência de elevado consumo de anorexígenos, possivelmente relacionada à preocupação com padrões estéticos atuais, o que ressalta a importância de um controle rigoroso sobre a comercialização destas substâncias.
Asunto(s)
Depresores del Apetito , Farmacias/clasificación , Comercialización de Medicamentos , Anfetaminas , Obesidad/clasificaciónRESUMEN
OBJECTIVES: To assess the possibility of bias due to the limited target list and geographic sampling of the World Health Organization (WHO)/Health Action International (HAI) Medicine Prices and Availability survey used in more than 70 rapid sample surveys since 2001. METHODS: A survey was conducted in Peru in 2005 using an expanded sample of medicine outlets, including remote areas. Comprehensive data were gathered on medicines in three therapeutic classes to assess the adequacy of WHO/HAI's target medicines list and the focus on only two product versions. WHO/HAI median retail prices were compared with average wholesale prices from global pharmaceutical sales data supplier IMS Health. RESULTS: No significant differences were found in overall availability or prices of target list medicines by retail location. The comprehensive survey of angiotensin-converting enzyme inhibitor, anti-diabetic, and anti-ulcer products revealed that some treatments not on the target list were costlier for patients and more likely to be unavailable, particularly in remote areas. WHO/HAI retail prices and IMS wholesale prices were strongly correlated for higher priced products, and weakly correlated for lower priced products (which had higher estimated retailer markups). CONCLUSIONS: The WHO/HAI survey approach strikes an appropriate balance between modest research costs and optimal information for policy. Focusing on commonly used medicines yields sufficient and valid results. Surveyors elsewhere should consider the limits of the survey data as well as any local circumstances, such as scarcity, that may call for extra field efforts.
Asunto(s)
Recolección de Datos/métodos , Honorarios Farmacéuticos/estadística & datos numéricos , Preparaciones Farmacéuticas/economía , Inhibidores de la Enzima Convertidora de Angiotensina/economía , Inhibidores de la Enzima Convertidora de Angiotensina/provisión & distribución , Antiinfecciosos/economía , Antiinfecciosos/provisión & distribución , Antiulcerosos/economía , Antiulcerosos/provisión & distribución , Anticonvulsivantes/economía , Anticonvulsivantes/provisión & distribución , Medicamentos Genéricos/economía , Medicamentos Genéricos/provisión & distribución , Hipoglucemiantes/economía , Hipoglucemiantes/provisión & distribución , Perú , Preparaciones Farmacéuticas/provisión & distribución , Farmacias/clasificación , Farmacias/economía , Farmacias/estadística & datos numéricos , Sector Público/economía , Muestreo , Organización Mundial de la SaludAsunto(s)
Recolección de Datos/métodos , Honorarios Farmacéuticos/estadística & datos numéricos , Preparaciones Farmacéuticas/economía , Inhibidores de la Enzima Convertidora de Angiotensina/economía , Inhibidores de la Enzima Convertidora de Angiotensina/provisión & distribución , Antiinfecciosos/economía , Antiinfecciosos/provisión & distribución , Antiulcerosos/economía , Antiulcerosos/provisión & distribución , Anticonvulsivantes/economía , Anticonvulsivantes/provisión & distribución , Medicamentos Genéricos/economía , Medicamentos Genéricos/provisión & distribución , Hipoglucemiantes/economía , Hipoglucemiantes/provisión & distribución , Perú , Preparaciones Farmacéuticas/provisión & distribución , Farmacias/clasificación , Farmacias/economía , Farmacias/estadística & datos numéricos , Sector Público/economía , Muestreo , Organización Mundial de la SaludRESUMEN
Objectives: To assess the possibility of bias due to the limited target list and geographic sampling of the World Health Organization (WHO)/Health Action International (HAI) Medicine Prices and Availability survey used in more than 70 rapid sample surveys since 2001. Methods: A survey was conducted in Peru in 2005 using an expanded sample of medicine outlets, including remote areas. Comprehensive data were gathered on medicines in three therapeutic classes to assess the adequacy of WHO/HAI's target medicines list and the focus on only two product versions. WHO/HAI median retail prices were compared with average wholesale prices from global pharmaceutical sales data supplier IMS Health. Results: No significant differences were found in overall availability or prices of target list medicines by retail location. The comprehensive survey of angiotensin-converting enzyme inhibitor, anti-diabetic, and anti-ulcer products revealed that some treatments not on the target list were costlier for patients and more likely to be unavailable, particularly in remote areas. WHO/HAI retail prices and IMS wholesale prices were strongly correlated for higher priced products, and weakly correlated for lower priced products (which had higher estimated retailer markups). Conclusions: The WHO/HAI survey approach strikes an appropriate balance between modest research costs and optimal information for policy. Focusing on commonly used medicines yields sufficient and valid results. Surveyors elsewhere should consider the limits of the survey data as well as any local circumstances, such as scarcity, that may call for extra field efforts.
Objetivos: Evaluar la posibilidad de sesgo debido a la limitación de la lista de referencia y del muestreo geográfico de la encuesta de precios y disponibilidad de medicamentos de la Organización Mundial de la Salud/Health Action International (OMS/HAI) usada en más de 70 muestras de encuestas rápidas desde el 2001. Métodos: En el año 2005, se realizó una encuesta en Perú, con una muestra ampliada de puntos de venta de medicamento, incluso en zonas remotas. Se recogieron datos integrales acerca de los medicamentos de tres clases terapéuticas, con el fin de evaluar la idoneidad de la lista de referencia de medicamentos de la OMS/HAI y el énfasis únicamente en dos versiones del producto. Las medianas de los precios al por menor de la OMS/HAI se compararon con el promedio de precios al por mayor del proveedor de datos mundiales de ventas farmacéuticas IMS Health. Resultados: No se observó ninguna diferencia significativa en la disponibilidad general ni en los precios de los medicamentos de la lista de referencia por localización de venta al por menor. La encuesta integral de los inhibidores de la enzima convertidora de la angiotensina, los antidiabéticos y los productos antiulcerosos reveló que algunos tratamientos que no están en la lista destinataria eran más caros para los pacientes y era más probable que no estuvieran a la venta, sobre todo en las regiones remotas. Los precios al por menor de la OMS/HAI y los precios al por mayor de IMS presentaron una correlación intensa en el caso de los productos de precio más alto, y la correlación fue débil en el caso de los productos de precio más bajo (que tuvieron márgenes de beneficio calculados más altos para el minorista). Conclusiones: El método de la encuesta de la OMS/HAI logra un equilibrio adecuado entre los costos de investigación moderados y la información óptima para la política. El énfasis en los medicamentos de uso frecuente produce unos resultados válidos y suficientes. Los encuestadores de otros...
Asunto(s)
Recolección de Datos/métodos , Honorarios Farmacéuticos/estadística & datos numéricos , Preparaciones Farmacéuticas/economía , Inhibidores de la Enzima Convertidora de Angiotensina/economía , Inhibidores de la Enzima Convertidora de Angiotensina/provisión & distribución , Antiinfecciosos/economía , Antiinfecciosos/provisión & distribución , Antiulcerosos/economía , Antiulcerosos/provisión & distribución , Anticonvulsivantes/economía , Anticonvulsivantes/provisión & distribución , Medicamentos Genéricos/economía , Medicamentos Genéricos/provisión & distribución , Hipoglucemiantes/economía , Hipoglucemiantes/provisión & distribución , Perú , Preparaciones Farmacéuticas/provisión & distribución , Farmacias/clasificación , Farmacias/economía , Farmacias/estadística & datos numéricos , Sector Público/economía , Muestreo , Organización Mundial de la SaludRESUMEN
El presente texto pretende dar un servicio real a la población sobre la actualidad de las diferentes ramas de la bioquímica y farmacia. Esta guía pretende ser un aporte a la población entre la cual se ha detectado la necesidad de un mayor conocimiento de las acciones y objetivos del Colegio Departamental de Bioquímica y Farmacia. Aquí se conoce el aporte de todos los profesionales del ramo, tanto del sector público como privado y en el área rural y urbana. Mediante D.S. No. 10083/72 del 14 de enero de 1972 se constituye la colegiación de los profesionales Bioquímicos-Farmaceúticos Bolivianos. Contiene el estatuto Orgánico, Reglamento, Código de Etica y Moral, Reglamento del Código de Etica del Colegio de Bioquímica y Farmacia de Bolivia, además de los profesionales del Colegio, Profesionales registrados al Diciembre de 1994 al 1995